ClinicalTrials.gg
CompletedNCT04535011PRACTUpdated Nov 4, 2026Results posted

PRACT to Investigate Controlling Alcohol Related Harms in a Low-Income Setting; Emergency Department BIs in Tanzania

An interventional study of PPKAY (brief intervention) and Standard Booster in Alcohol Use Disorder, Injury Traumatic and Trauma, sponsored by Duke University. Completed at 1 site in Tanzania. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Duke University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 4, 2026Results postedStudy documents posted+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
673
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Alcohol use is rapidly increasing in low- and middle-income countries, where it is inexpensive, readily available, poorly regulated, and there are few resources devoted to promoting safe alcohol use. A Brief Intervention based on a motivational interviewing framework has been shown to reduce alcohol use and alcohol-related harms. The investigators have translated and adapted a Brief Intervention for alcohol to the Tanzanian context and Swahili language called "Punguza Pombe Kwa Afya Yako (PPKAY)/ Reduce Alcohol for Your Health." This project will evaluate this intervention in injury patients presenting for care at the Kilimanjaro Christian Medical Center in Moshi, Tanzania. By using innovative adaptive clinical trial methods, the investigators will expedite the development of the most effective way to integrate this intervention into clinical care. By the end of this project, investigators will have identified the most effective brief intervention components and be able to characterize the intervention's effect overall. Additionally, investigators will standardize adaptive trial methods to revolutionize the science of clinical trials for behavioral sciences in low-resource settings.

02

Conditions studied

  • Alcohol Use Disorder
  • Injury Traumatic
  • Trauma
03

In context

Alcoholism

1,679 studies on the registry are indexed under Alcoholism; 333 are open to participants now.

This study's enrollment of 673 is above the median of 88 across 1,433 interventional studies indexed under Alcoholism.

Browse Alcoholism studies →

Lead sponsor

Duke University is the lead sponsor of 2,064 studies on the registry; 271 are open to participants now.

Of its 204 completed or terminated interventional studies of FDA-regulated products, 170 (83%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥18 years of age)
  • present seeking initial care at the KCMC ED for an acute (\<24 hours) injury
  • not clinically intoxicated (i.e., have capacity to consent).
  • one or more of the following: 1) disclosed alcohol use prior to injury, 2) scored ≥8 on the AUDIT, 3) test positive (>0.0 g/dL) by alcohol breathalyzer.

Exclusion criteria

Exclusion Criteria:

  • do not speak the native Swahili language
  • too ill or unable to communicate
  • prior enrollment in this study
  • decline .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
673 participants (actual)

Study arms

  • No intervention
    Usual Care

    No prevention or educational information verbally or written coinciding with current usual care

  • Experimental
    PPKAY

    One-time, 15-minute, nurse-led motivational interview discussing safe drinking behaviors, and negotiating change in alcohol use

    Behavioral: PPKAY (brief intervention)

  • Experimental
    PPKAY with Standard Booster

    One-time, 15-minute, nurse-led motivational interview discussing safe drinking behaviors, and negotiating change in alcohol use. Weekly standard text booster until final follow-up (e.g., "Reducing your alcohol intake to less than 4 drinks per day reduces your risk of alcohol-related consequences")

    Behavioral: PPKAY (brief intervention) · Behavioral: Standard Booster

  • Experimental
    PPKAY with Personalized Booster

    One-time, 15-minute, nurse-led motivational interview discussing safe drinking behaviors, and negotiating change in alcohol use Weekly personalized text booster until final follow-up (e.g., "Remember to reduce your alcohol less than 4 drinks to achieve your goal of… \[being a better husband\].")

    Behavioral: PPKAY (brief intervention) · Behavioral: Personalized Booster

Interventions

  • BehavioralPPKAY (brief intervention)

    PPKAY is a nurse-administered, one-on-one, 15-minute brief intervention (BI) for alcohol use using FRAMES motivational interviewing techniques. The BI is a four-step discussion: 1) Raise the Subject of Alcohol, 2) Provide Feedback, 3) Enhance Motivation 4) Negotiate and Advice.

  • BehavioralStandard Booster

    After discharge from the hospital, a standard motivational text message will be sent to their cell phone twice monthly for the duration of the study. In a rotating fashion, one of four standard motivational texts translated into Swahili will be sent to their cell phones.

  • BehavioralPersonalized Booster

    After discharge from the hospital, a personalized motivational text message will be sent to participant cell phones twice monthly for the duration of the study. In a rotating fashion, one of four personalized motivational texts will be sent to their cell phones. Personalized texts will be created with the content obtained from the motivational interview sessions. At each session, the research nurse conducting the intervention will record four messages based on the content of the session to be sent as the Personalized Booster.

06

What researchers measure

Primary outcomes

  1. Number of Binge Drinking Days (Previous 4 Weeks)

    Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months

Secondary outcomes

  1. Frequency of Alcohol Use (Previous 2 Weeks)

    Reported as the number of drinking days during the past two weeks.

    Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months

  2. Quantity of Alcohol Use (Previous 2 Weeks)

    Reported as the number of drinks consumed during the past two weeks.

    Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months

  3. Alcohol-related Harms Measured by the Drinker Inventory of Consequences (DrInC)

    The Drinker Inventory of Consequences (DrInC) is a fifty-item questionnaire with scores ranging from 0 to 150, where a higher number indicates a greater number of negative consequences.

    Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months

  4. AUDIT (Alcohol Use Disorder Identification Test) Score

    Alcohol use disorder as measured by AUDIT (alcohol use disorder identification test) score. AUDIT is a ten-item tool, with scores ranging from 0 to 40, where a higher score indicates higher risk alcohol use.

    Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months

  5. Depression as Measured by Patient Health Questionnaire 9 (PHQ-9)

    The PHQ-9 consists of 9 simple questions evaluating core symptoms of depression over the past two weeks. Each item is rated on a scale of 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 27, with higher scores indicating greater symptom severity.

    Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months

07

Results

Posted Nov 4, 2026

Participant flow

Stage I
Participant flow — Stage I
MilestoneStage I: Usual CareStage I: PPKAY With Standard BoosterStage I: PPKAY With Personalized BoosterStage II: PPKAY
Started1712032100
Completed1291311100
Not completed42721000
Stage II
Participant flow — Stage II
MilestoneStage I: Usual CareStage I: PPKAY With Standard BoosterStage I: PPKAY With Personalized BoosterStage II: PPKAY
Started00089
Completed0001
Not completed00088

Outcome measures

PrimaryNumber of Binge Drinking Days (Previous 4 Weeks)
Time frame:
Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
Reported as:
Mean · days
Number of Binge Drinking Days (Previous 4 Weeks)
daysUsual CarePPKAYPPKAY With Standard BoosterPPKAY With Personalized Booster
Baseline3.7 ± 7.04.3 ± 7.64.2 ± 7.34.1 ± 6.7
3 months0.9 ± 3.81.2 ± 4.90.6 ± 3.00.3 ± 2.3
6 months1.3 ± 4.70.5 ± 1.40.7 ± 2.90.4 ± 2.5
9 months1.5 ± 4.50.6 ± 1.50.8 ± 3.80.3 ± 1.3
12 months1.6 ± 4.30.8 ± 2.01.1 ± 4.30.3 ± 1.4
24 months2.5 ± 6.8—0.7 ± 2.90.2 ± 1.0
Statistical analysis
  • Usual Care vs PPKAY vs PPKAY With Standard Booster vs PPKAY With Personalized Booster · Mixed Models Analysis · p = 0.002 · Mean difference (final values): -1.2 · 95% CI -2.3 to -0.3Mixed effects zero inflated negative binomial regression
SecondaryFrequency of Alcohol Use (Previous 2 Weeks)

Reported as the number of drinking days during the past two weeks.

Time frame:
Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
Reported as:
Mean · days
Frequency of Alcohol Use (Previous 2 Weeks)
daysUsual CarePPKAYPPKAY With Standard BoosterPPKAY With Personalized Booster
Baseline4.0 ± 3.94.8 ± 4.34.1 ± 3.83.9 ± 3.6
3 months1.3 ± 3.21.4 ± 3.20.7 ± 2.00.6 ± 2.0
6 months1.6 ± 3.21.0 ± 2.20.8 ± 1.90.6 ± 2.0
9 months1.7 ± 3.50.7 ± 1.21.0 ± 2.50.8 ± 2.2
12 months1.8 ± 3.41.5 ± 2.41.1 ± 2.70.8 ± 2.3
24 months2.2 ± 4.1—1.2 ± 2.41.0 ± 2.6
SecondaryQuantity of Alcohol Use (Previous 2 Weeks)

Reported as the number of drinks consumed during the past two weeks.

Time frame:
Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
Reported as:
Mean · drinks
Quantity of Alcohol Use (Previous 2 Weeks)
drinksUsual CarePPKAYPPKAY With Standard BoosterPPKAY With Personalized Booster
Baseline22.9 ± 35.626.6 ± 37.822.7 ± 34.721.4 ± 35.6
3 months5.0 ± 13.010.2 ± 31.53.7 ± 16.72.2 ± 9.9
6 months6.5 ± 15.84.3 ± 10.93.4 ± 9.72.2 ± 8.5
9 months7.3 ± 19.93.4 ± 6.85.4 ± 17.63.3 ± 10.4
12 months9.7 ± 28.26.3 ± 10.95.8 ± 17.32.3 ± 7.2
24 months12.3 ± 30.5—4.9 ± 11.52.6 ± 7.3
SecondaryAlcohol-related Harms Measured by the Drinker Inventory of Consequences (DrInC)

The Drinker Inventory of Consequences (DrInC) is a fifty-item questionnaire with scores ranging from 0 to 150, where a higher number indicates a greater number of negative consequences.

Time frame:
Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
Reported as:
Mean · score on a scale
Alcohol-related Harms Measured by the Drinker Inventory of Consequences (DrInC)
score on a scaleUsual CarePPKAYPPKAY With Standard BoosterPPKAY With Personalized Booster
Baseline14.4 ± 16.315.7 ± 15.613.2 ± 15.413.4 ± 7.3
3 months2.8 ± 7.86.7 ± 8.62.0 ± 7.54.0 ± 4.4
6 months5.5 ± 11.46.5 ± 10.12.9 ± 7.04.4 ± 4.1
9 months3.7 ± 8.94.2 ± 5.95.1 ± 11.65.1 ± 5.0
12 months5.9 ± 11.28.3 ± 20.34.5 ± 9.64.6 ± 5.1
24 months8.8 ± 12.5—8.0 ± 14.33.6 ± 3.9
SecondaryAUDIT (Alcohol Use Disorder Identification Test) Score

Alcohol use disorder as measured by AUDIT (alcohol use disorder identification test) score. AUDIT is a ten-item tool, with scores ranging from 0 to 40, where a higher score indicates higher risk alcohol use.

Time frame:
Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
Reported as:
Mean · score on a scale
AUDIT (Alcohol Use Disorder Identification Test) Score
score on a scaleUsual CarePPKAYPPKAY With Standard BoosterPPKAY With Personalized Booster
Baseline13.3 ± 7.111.7 ± 7.013.1 ± 7.713.4 ± 7.3
3 months3.9 ± 4.15.2 ± 4.54.1 ± 4.34.0 ± 4.4
6 months5.3 ± 5.85.0 ± 5.14.4 ± 4.74.4 ± 4.1
9 months5.0 ± 4.95.7 ± 4.95.0 ± 4.95.1 ± 5.0
12 months5.1 ± 5.25.7 ± 5.84.6 ± 4.84.6 ± 5.1
24 months5.4 ± 5.5—4.8 ± 5.13.6 ± 3.9
SecondaryDepression as Measured by Patient Health Questionnaire 9 (PHQ-9)

The PHQ-9 consists of 9 simple questions evaluating core symptoms of depression over the past two weeks. Each item is rated on a scale of 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 27, with higher scores indicating greater symptom severity.

Time frame:
Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
Reported as:
Mean · score on a scale
Depression as Measured by Patient Health Questionnaire 9 (PHQ-9)
score on a scaleUsual CarePPKAYPPKAY With Standard BoosterPPKAY With Personalized Booster
Baseline3.1 ± 4.03.0 ± 4.53.0 ± 3.73.8 ± 4.4
3 months3.4 ± 4.23.4 ± 4.03.4 ± 4.04.1 ± 4.4
6 months3.9 ± 5.02.5 ± 3.62.7 ± 3.13.4 ± 3.7
9 months2.7 ± 3.32.2 ± 4.22.4 ± 3.32.9 ± 3.6
12 months3.3 ± 4.11.4 ± 2.42.8 ± 4.03.1 ± 3.9
24 months2.6 ± 3.2—2.2 ± 2.82.3 ± 3.5

Adverse events

Collected over Up to 24 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Usual Care5/171 (2.9%)0/171 (0%)0/171 (0%)
PPKAY1/89 (1.1%)0/89 (0%)0/89 (0%)
PPKAY With Standard Booster4/203 (2%)0/203 (0%)0/203 (0%)
PPKAY With Personalized Booster5/210 (2.4%)0/210 (0%)0/210 (0%)

Baseline characteristics

Stage II only included the PPKAY-only participants.

Age, Continuous
Age, Continuous(years)Stage I: Usual CareStage II: PPKAYStage I: PPKAY With Standard BoosterStage I: PPKAY With Personalized BoosterTotal
Mean36 ± 1237 ± 1436 ± 1237 ± 1336 ± 13
Sex: Female, Male
Sex: Female, Male(Participants)Stage I: Usual CareStage II: PPKAYStage I: PPKAY With Standard BoosterStage I: PPKAY With Personalized BoosterTotal
Female98111543
Male16281192195630
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Stage I: Usual CareStage II: PPKAYStage I: PPKAY With Standard BoosterStage I: PPKAY With Personalized BoosterTotal
Hispanic or Latino00000
Not Hispanic or Latino17189203210673
Unknown or Not Reported00000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Stage I: Usual CareStage II: PPKAYStage I: PPKAY With Standard BoosterStage I: PPKAY With Personalized BoosterTotal
American Indian or Alaska Native00000
Asian00000
Native Hawaiian or Other Pacific Islander00000
Black or African American17189202210672
White00101
More than one race00000
Unknown or Not Reported00000
Region of Enrollment
Region of Enrollment(Participants)Stage I: Usual CareStage II: PPKAYStage I: PPKAY With Standard BoosterStage I: PPKAY With Personalized BoosterTotal
Tanzania17189203210673
08

Study locations

1 site
  • Kilimanjaro Christian Medical Centre
    Moshi, Kilimanjaro, Tanzania
09

References and documents

Publications

  • Staton CA, Minja L, de Souza JVP, Gallis JA, Santos PCP, Buono M, Sakita F, Ngowi K, Boshe J, Phillips AJ, Vissoci JRN, Mmbaga BT. Effectiveness of a brief intervention and text-based booster in the emergency department to reduce harmful and hazardous alcohol use: A pragmatic randomized adaptive clinical trial in Moshi, Tanzania. PLoS Med. 2025 Oct 27;22(10):e1004548. doi: 10.1371/journal.pmed.1004548. eCollection 2025 Oct. PubMed 41144564 ↗
  • Staton CA, Agnihotri D, Phillips AJ, Ngowi K, Huo L, Boshe J, Sakita F, Tupetz A, Suffoletto B, Mmbaga BT, Vissoci JRN. Development of culturally-appropriate text message booster content to follow a brief intervention focused on reducing alcohol related harms for injury patients in Moshi, Tanzania. PLOS Glob Public Health. 2024 Jul 25;4(7):e0002717. doi: 10.1371/journal.pgph.0002717. eCollection 2024. PubMed 39052647 ↗
  • Staton CA, Zadey S, O'Leary P, Phillips A, Minja L, Swahn MH, Hirshon JM, Boshe J, Sakita F, Vissoci JRN, Mmbaga BT. PRACT: a pragmatic randomized adaptive clinical trial protocol to investigate a culturally adapted brief negotiational intervention for alcohol use in the emergency department in Tanzania. Trials. 2022 Feb 5;23(1):120. doi: 10.1186/s13063-022-06060-y. PubMed 35123566 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2020 to primary completion in May 2025, 55 months.

Results were first posted in Nov 2026, 1 year 5 months after primary completion.

Of 472 non-industry interventional studies with no phase under Alcoholism, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 54. This study's 55 months is above that.

Counting every sponsor, half of 495 studies reached it within 33 months; a quarter within 17 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 27, 2020
First posted
Sep 1, 2020
StartActual
Oct 12, 2020
Primary completionActual
May 30, 2025
CompletionActual
May 30, 2025
Results first posted
Nov 4, 2026
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Nov 4, 2026
Enrollment
674→673
Nov 4, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedChange in numberNumber of binge drinking daysBinge Drinking Days (previousPrevious 4 weeksWeeks)Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
Nov 4, 2026
Secondary outcomes
3 edited, 2 added, 2 removed
What changed in the outcomes
  • EditedChange in frequencyFrequency of alcohol useAlcohol Use (previousPrevious 2 weeksWeeks)Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
  • EditedChange in quantityQuantity of alcohol useAlcohol Use (previousPrevious 2 weeksWeeks)Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
  • EditedChange in alcoholAlcohol-related harms measuredHarms Measured by the Drinker Inventory of Consequences (DrInC)Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
  • AddedAUDIT (Alcohol Use Disorder Identification Test) ScoreTime frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
  • AddedDepression as Measured by Patient Health Questionnaire 9 (PHQ-9)Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
  • RemovedChange in alcohol use disorderTime frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
  • RemovedChange in depressionTime frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Results posted
    Enrollment 674→673
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedChange in numberNumber of binge drinking daysBinge Drinking Days (previousPrevious 4 weeksWeeks)Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
    Secondary outcomes 3 edited, 2 added, 2 removed
    What changed in the outcomes
    • EditedChange in frequencyFrequency of alcohol useAlcohol Use (previousPrevious 2 weeksWeeks)Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
    • EditedChange in quantityQuantity of alcohol useAlcohol Use (previousPrevious 2 weeksWeeks)Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
    • EditedChange in alcoholAlcohol-related harms measuredHarms Measured by the Drinker Inventory of Consequences (DrInC)Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
    • AddedAUDIT (Alcohol Use Disorder Identification Test) ScoreTime frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
    • AddedDepression as Measured by Patient Health Questionnaire 9 (PHQ-9)Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
    • RemovedChange in alcohol use disorderTime frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
    • RemovedChange in depressionTime frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
    + 3 other changes: index terms, verification date and registry notes

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT04535011
Lead sponsor
Duke University
Collaborators
Kilimanjaro Christian Medical Centre, Tanzania, National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Responsible party
Sponsor
First posted
Sep 1, 2020
Start date
Oct 12, 2020
Primary completion
May 30, 2025
Completion
May 30, 2025
Results posted
Nov 4, 2026
Last update
Nov 4, 2026

Study contacts

Catherine A Staton, MD
principal investigator · Duke University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion